Effects of C-reactive Protein Trajectories of Critically Ill Patients with Sepsis on In-hospital Mortality Rate

Overview

Journal Sci Rep

Specialty Science

Date 2023 Sep 14

PMID 37709919

Authors

Xuandong Jiang

Chenlu Zhang

Yuting Pan

Xuping Cheng

Weimin Zhang

Affiliations

Soon will be listed here.

Abstract

Sepsis, a life-threatening condition caused by an inflammatory response to systemic infection, results in a significant social burden and healthcare costs. This study aimed to investigate the relationship between the C-reactive protein (CRP) trajectories of patients with sepsis in the intensive care unit (ICU) and the in-hospital mortality rate. We reviewed 1464 patients with sepsis treated in the ICU of Dongyang People's Hospital from 2010 to 2020 and used latent growth mixture modeling to divide the patients into four classes according to CRP trajectory (intermediate, gradually increasing, persistently high, and persistently low CRP levels). We found that patients with intermediate and persistently high CRP levels had the lowest (18.1%) and highest (32.6%) in-hospital mortality rates, respectively. Multiple logistic regression analysis showed that patients with persistently high (odds ratio [OR] = 2.19, 95% confidence interval [CI] = 1.55-3.11) and persistently low (OR = 1.41, 95% CI = 1.03-1.94) CRP levels had a higher risk of in-hospital mortality than patients with intermediate CRP levels. In conclusion, in-hospital mortality rates among patients with sepsis differ according to the CRP trajectory, with patients with intermediate CRP levels having the lowest mortality rate. Further research on the underlying mechanisms is warranted.

Citing Articles

The effect of therapeutic plasma exchange on the inflammatory response in septic shock: a secondary analysis of the EXCHANGE-1 trial.

Sauer A, Stahl K, Seeliger B, Wendel-Garcia P, Lehmann F, Schmidt J Intensive Care Med Exp. 2025; 13(1):18.

PMID: 39951217 PMC: 11828778. DOI: 10.1186/s40635-025-00725-z.

Everything's under Control: Maximizing Biosensor Performance through Negative Control Probe Selection.

Bucukovski J, Miller B Anal Chem. 2025; 97(6):3525-3535.

PMID: 39898999 PMC: 11840803. DOI: 10.1021/acs.analchem.4c05854.

Host Response in Critically Ill Patients Aged 65 Years or Older: A Prospective Study.

Lian H, Wang G, Zhang H, Wang X, Zhang S Clin Interv Aging. 2024; 19:1789-1805.

PMID: 39507695 PMC: 11539842. DOI: 10.2147/CIA.S483704.

Role of C-reactive Protein and Procalcitonin in Early Diagnostic Accuracy and Their Prognostic Significance in Sepsis.

Daud M, Khan M, Qudrat Q, Ullah I, Khan S, Khan M Cureus. 2024; 16(9):e70358.

PMID: 39469363 PMC: 11513552. DOI: 10.7759/cureus.70358.

The value of C-reactive protein velocity (CRPv) on mortality in sepsis patients who are emergently hospitalized in the ICU: A retrospective single-center study.

Kilinc Toker A, Celik I, Turunc Ozdemir A, Saglam H, Kocer D, Eslik M Heliyon. 2024; 10(19):e38797.

PMID: 39397922 PMC: 11471266. DOI: 10.1016/j.heliyon.2024.e38797.

References

Fleischmann C, Scherag A, Adhikari N, Hartog C, Tsaganos T, Schlattmann P . Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2015; 193(3):259-72. DOI: 10.1164/rccm.201504-0781OC. View

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith C, French C . Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021; 49(11):e1063-e1143. DOI: 10.1097/CCM.0000000000005337. View

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

Prest J, Sathananthan M, Jeganathan N . Current Trends in Sepsis-Related Mortality in the United States. Crit Care Med. 2021; 49(8):1276-1284. DOI: 10.1097/CCM.0000000000005017. View

Fleischmann-Struzek C, Mellhammar L, Rose N, Cassini A, Rudd K, Schlattmann P . Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020; 46(8):1552-1562. PMC: 7381468. DOI: 10.1007/s00134-020-06151-x. View

Tan M, Lu Y, Jiang H, Zhang L . The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis. J Cell Biochem. 2018; 120(4):5852-5859. DOI: 10.1002/jcb.27870. View

Liang P, Yu F . Value of CRP, PCT, and NLR in Prediction of Severity and Prognosis of Patients With Bloodstream Infections and Sepsis. Front Surg. 2022; 9:857218. PMC: 8957078. DOI: 10.3389/fsurg.2022.857218. View

Plebani M . Why C-reactive protein is one of the most requested tests in clinical laboratories?. Clin Chem Lab Med. 2023; 61(9):1540-1545. DOI: 10.1515/cclm-2023-0086. View

Grander W, Dunser M, Stollenwerk B, Siebert U, Dengg C, Koller B . C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest. 2010; 138(4):856-62. DOI: 10.1378/chest.09-1677. View

10.

Molins B, Figueras-Roca M, Valero O, Llorenc V, Romero-Vazquez S, Sibila O . C-reactive protein isoforms as prognostic markers of COVID-19 severity. Front Immunol. 2023; 13:1105343. PMC: 9893772. DOI: 10.3389/fimmu.2022.1105343. View

11.

van Genderen M, Lima A, de Geus H, Klijn E, Wijnhoven B, Gommers D . Serum C-reactive protein as a predictor of morbidity and mortality in intensive care unit patients after esophagectomy. Ann Thorac Surg. 2011; 91(6):1775-9. DOI: 10.1016/j.athoracsur.2011.02.042. View

12.

Zhang Z, Ho K, Gu H, Hong Y, Yu Y . Defining persistent critical illness based on growth trajectories in patients with sepsis. Crit Care. 2020; 24(1):57. PMC: 7029548. DOI: 10.1186/s13054-020-2768-z. View

13.

Moulin F, Jean F, Melchior M, Patane M, Pinucci I, Sijbrandij M . Longitudinal impact of the COVID19 pandemic on mental health in a general population sample in France: Evidence from the COMET Study. J Affect Disord. 2022; 320:275-283. PMC: 9525187. DOI: 10.1016/j.jad.2022.09.142. View

14.

Min J . A longitudinal study of cognitive trajectories and its factors for Koreans aged 60 and over: A latent growth mixture model. Int J Geriatr Psychiatry. 2018; 33(5):755-762. DOI: 10.1002/gps.4855. View

15.

Zhang Z, Gayle A, Wang J, Zhang H, Cardinal-Fernandez P . Comparing baseline characteristics between groups: an introduction to the CBCgrps package. Ann Transl Med. 2018; 5(24):484. PMC: 5750271. DOI: 10.21037/atm.2017.09.39. View

16.

Lennon H, Kelly S, Sperrin M, Buchan I, Cross A, Leitzmann M . Framework to construct and interpret latent class trajectory modelling. BMJ Open. 2018; 8(7):e020683. PMC: 6042544. DOI: 10.1136/bmjopen-2017-020683. View

17.

Gulcher S, Bruins N, Kingma W, Boerma E . Elevated C-reactive protein levels at ICU discharge as a predictor of ICU outcome: a retrospective cohort study. Ann Intensive Care. 2016; 6(1):5. PMC: 4710625. DOI: 10.1186/s13613-016-0105-0. View

18.

Karadeniz G, Polat G, Senol G, Buyuksirin M . C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations. Inflammation. 2013; 36(4):948-53. DOI: 10.1007/s10753-013-9625-z. View

19.

Yang Y, Xie J, Guo F, Longhini F, Gao Z, Huang Y . Combination of C-reactive protein, procalcitonin and sepsis-related organ failure score for the diagnosis of sepsis in critical patients. Ann Intensive Care. 2016; 6(1):51. PMC: 4901212. DOI: 10.1186/s13613-016-0153-5. View

20.

Zeller J, Bogner B, McFadyen J, Kiefer J, Braig D, Pietersz G . Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: Therapeutic implications for cardiovascular diseases. Pharmacol Ther. 2022; 235:108165. DOI: 10.1016/j.pharmthera.2022.108165. View